Quicksilver Biosciences
Quicksilver Biosciences: A VC-backed biotech startup innovating rapid genomic identification through advanced biosensors.
Founded
2018Quicksilver Biosciences: A VC-backed biotech startup innovating rapid genomic identification through advanced biosensors.
Quicksilver Biosciences, founded in New York City, is a venture capital-backed biotech startup focused on revolutionizing rapid genomic identification. The company's core mission is to develop a versatile CMOS-integrated biosensor platform that offers superior sensitivity compared to current technologies. By leveraging proprietary sensing techniques, Quicksilver aims to provide a portable and cost-effective solution for genomic identification, targeting applications in healthcare, research, and diagnostics.
Notable figures associated with Quicksilver Biosciences include leading experts in biosensor technology and genomic research, though specific names are not publicly disclosed due to the company's current stealth mode. Key achievements include securing venture capital funding and developing a cutting-edge biosensor platform that promises to set new standards in sensitivity and portability. The overall impact of Quicksilver Biosciences lies in its potential to significantly advance genomic identification, making it more accessible and efficient for various scientific and medical applications.
Companies similar to Quicksilver Biosciences include Innovative Biosensors, Singular Genomics, Bialanx and Data Driven Bioscience.
Quicksilver Biosciences was founded in 2018.
Quicksilver Biosciences' headquarters is located in New York City, NY, US.
Quicksilver Biosciences' most recent funding round was for $255.7k (USD) in September 2020.
As of Sep 1, 2020, Quicksilver Biosciences has raised a total of $480.7k (USD).
Quicksilver Biosciences has 3 employees as of Feb 4, 2024.
bialanx.com
